Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
![]() |
Targeting Unconscionable Prescription-Drug Prices — Maryland’s Anti–Price-Gouging LawThe New England journal of medicine, 2017-07, Vol.377 (2), p.101-103 [Peer Reviewed Journal]Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMp1704907 ;PMID: 28591520Full text available |
2 |
Material Type: Article
|
![]() |
Dying to survive and cancer care in ChinaThe lancet oncology, 2019-01, Vol.20 (1), p.30-30 [Peer Reviewed Journal]2019 Elsevier Ltd ;Copyright Elsevier Limited Jan 2019 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(18)30921-5 ;PMID: 30614464Full text available |
3 |
Material Type: Article
|
![]() |
Limiting State Flexibility in Drug PricingThe New England journal of medicine, 2018-09, Vol.379 (11), p.1002-1004 [Peer Reviewed Journal]Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMp1809358 ;PMID: 30207910Full text available |
4 |
Material Type: Article
|
![]() |
If PBMs Guard Access to Drugs, Then Quis Custodiet Ipsos Custodies? (Who Will Guard the Guardians?)Journal of diabetes science and technology, 2016-11, Vol.10 (6), p.1406-1410 [Peer Reviewed Journal]2016 Diabetes Technology Society ;2016 Diabetes Technology Society. ;2016 Diabetes Technology Society 2016 Diabetes Technology Society ;ISSN: 1932-2968 ;EISSN: 1932-2968 ;DOI: 10.1177/1932296816658056 ;PMID: 27381029Full text available |
5 |
Material Type: Article
|
![]() |
US Senate committee launches investigation into drug pricingBMJ (Online), 2015-11, Vol.351 (nov09 10), p.h5989-h5989 [Peer Reviewed Journal]BMJ Publishing Group Ltd 2015 ;Copyright BMJ Publishing Group LTD Nov 9, 2015 ;ISSN: 0959-8138 ;ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.h5989 ;PMID: 26553078Full text available |
6 |
Material Type: Article
|
![]() |
US seeking more transparency from pharmaCanadian Medical Association journal (CMAJ), 2016-04, Vol.188 (7), p.E115-E115 [Peer Reviewed Journal]COPYRIGHT 2016 Joule Inc. ;Copyright 8872147 Canada Inc. Apr 19, 2016 ;2016 8872147 Canada Inc. or its licensors 2016 ;ISSN: 0820-3946 ;EISSN: 1488-2329 ;DOI: 10.1503/cmaj.109-5245 ;PMID: 26976964 ;CODEN: CMAJAXFull text available |
7 |
Material Type: Article
|
![]() |
A Case Study of Pharmaceutical Pricing in China: Setting the Price for Off-Patent OriginatorsApplied health economics and health policy, 2015-08, Vol.13 (Suppl 1), p.13-20 [Peer Reviewed Journal]The Author(s) 2015 ;Copyright Springer Science & Business Media Aug 2015 ;ISSN: 1175-5652 ;EISSN: 1179-1896 ;DOI: 10.1007/s40258-014-0150-5 ;PMID: 26091710Full text available |
8 |
Material Type: Article
|
![]() |
Financial Effects of Pharmaceutical Price Regulation on R&D Spending by EU versus US FirmsPharmacoEconomics, 2010-08, Vol.28 (8), p.615-628 [Peer Reviewed Journal]Adis Data Information BV 2010 ;2015 INIST-CNRS ;COPYRIGHT 2010 Wolters Kluwer Health, Inc. ;COPYRIGHT 2010 Springer ;Copyright Wolters Kluwer Health Adis International Aug 2010 ;ISSN: 1170-7690 ;EISSN: 1179-2027 ;DOI: 10.2165/11535580-000000000-00000 ;PMID: 20617857Full text available |
9 |
Material Type: Article
|
![]() |
Ninth Circuit dismisses pharmacy benefit managers' First Amendment challenge to California statute mandating disclosure of pharmacies' retail drug pricing plan--Beeman v. Anthem Prescription ManagementAmerican journal of law & medicine, 2011-12, Vol.37 (4), p.687-689 [Peer Reviewed Journal]COPYRIGHT 2011 Sage Publications, Inc. ;COPYRIGHT 2011 American Society of Law, Medicine & Ethics ;COPYRIGHT 2011 Sage Publications, Inc. ;ISSN: 0098-8588 ;EISSN: 2375-835X ;DOI: 10.1017/S009885880000109X ;PMID: 22292217Full text available |
10 |
Material Type: Article
|
![]() |
Presenting Germany’s drug pricing rule as a cost-per-QALY ruleHealth care management science, 2012-06, Vol.15 (2), p.103-107 [Peer Reviewed Journal]Springer Science+Business Media, LLC 2011 ;Springer Science+Business Media, LLC 2012 ;ISSN: 1386-9620 ;EISSN: 1572-9389 ;DOI: 10.1007/s10729-011-9186-3 ;PMID: 22187356Full text available |
11 |
Material Type: Article
|
![]() |
Price Controls And Global Pharmaceutical ProgressHealth Affairs, 2009-01, Vol.28 (1), p.w161 [Peer Reviewed Journal]Copyright The People to People Health Foundation, Inc., Project HOPE 2009 ;ISSN: 0278-2715 ;EISSN: 1544-5208 ;EISSN: 2694-233X ;DOI: 10.1377/hlthaff.28.1.w161 ;PMID: 19088103Full text available |
12 |
Material Type: Article
|
![]() |
Effects of Medicaid Drug-Payment Limits on Admission to Hospitals and Nursing HomesThe New England journal of medicine, 1991-10, Vol.325 (15), p.1072-1077 [Peer Reviewed Journal]1992 INIST-CNRS ;Copyright Massachusetts Medical Society Oct 10, 1991 ;Copyright Massachusetts Medical Society, Publishing Division Oct 10, 1991 ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJM199110103251505 ;PMID: 1891009 ;CODEN: NEJMAGFull text available |
13 |
Material Type: Article
|
![]() |
User-fee bill passes US Senate, but legislative hurdles remainNature biotechnology, 2007-06, Vol.25 (6), p.611-611 [Peer Reviewed Journal]COPYRIGHT 2007 Nature Publishing Group ;Copyright Nature Publishing Group Jun 2007 ;ISSN: 1087-0156 ;EISSN: 1546-1696 ;DOI: 10.1038/nbt0607-611 ;PMID: 17557086Full text available |
14 |
Material Type: Article
|
![]() |
The Impact of Reference Pricing of Nonsteroidal Anti-Inflammatory Agents on the Use and Costs of Analgesic DrugsHealth services research, 2005-10, Vol.40 (5p1), p.1297-1317 [Peer Reviewed Journal]COPYRIGHT 2005 Health Research and Educational Trust ;2005 Health Research and Education Trust. All rights reserved ;2005 Health Research and Education Trust. All rights reserved 2005 ;ISSN: 0017-9124 ;EISSN: 1475-6773 ;DOI: 10.1111/j.1475-6773.2005.00420.x ;PMID: 16174135 ;CODEN: HESEA5Full text available |
15 |
Material Type: Article
|
![]() |
Congress moves on drug benefit bill for elderlyThe Lancet (British edition), 2002-08, Vol.360 (9330), p.396 [Peer Reviewed Journal]Copyright Lancet Ltd. Aug 3, 2002 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(02)09630-7 ;PMID: 12241793 ;CODEN: LANCAOFull text available |
16 |
Material Type: Article
|
![]() |
Pharmaceutical pricing, price controls, and their effects on pharmaceutical sales and research and development expenditures in the European UnionClinical therapeutics, 2004-08, Vol.26 (8), p.1327-1340 [Peer Reviewed Journal]2004 Excerpta Medica, Inc. ;2004 INIST-CNRS ;ISSN: 0149-2918 ;EISSN: 1879-114X ;DOI: 10.1016/S0149-2918(04)80209-1 ;PMID: 15476914Full text available |
17 |
Material Type: Article
|
![]() |
Recent Developments in Health LawThe Journal of law, medicine & ethics, 2008, Vol.36 (1), p.191-199 [Peer Reviewed Journal]2008 American Society of Law, Medicine & Ethics ;2008 American Society of Law, Medicine & Ethics, Inc. ;Copyright © American Society of Law, Medicine and Ethics 2008 ;ISSN: 1073-1105 ;EISSN: 1748-720X ;DOI: 10.1111/j.1748-720X.2008.00248.x ;PMID: 18315772Full text available |
18 |
Material Type: Article
|
![]() |
Time will judge 'scary' dispensing regulationsSouth African medical journal, 2004-10, Vol.94 (10), p.809 [Peer Reviewed Journal]ISSN: 0256-9574 ;PMID: 15532750Full text available |
19 |
Material Type: Article
|
![]() |
The Strategic Response by Pharmaceutical Firms to the Medicaid Most- Favored-Customer RulesThe Rand journal of economics, 1997, Vol.28 (2), p.269-290 [Peer Reviewed Journal]Copyright 1997 RAND ;Copyright Rand Corporation Summer 1997 ;ISSN: 0741-6261 ;EISSN: 1756-2171 ;DOI: 10.2307/2555805 ;PMID: 11794358 ;CODEN: RJECEAFull text available |
20 |
Material Type: Article
|
![]() |
Drug pricing: the end of the gravy train?South African medical journal, 2003-11, Vol.93 (11), p.812 [Peer Reviewed Journal]ISSN: 0256-9574 ;PMID: 14677496Full text available |